No increase in small-solute transport in peritoneal dialysis patients treated without hypertonic glucose for fifty-four months
BMC Nephrology Sep 14, 2017
Pagniez D, et al. - Experts planned an investigation to gauge the potential protective effect of a reduced exposure to hypertonic glucose. This large series exhibited a link between minimizing the use of hypertonic glucose solutions and an overall decrease of small-solute transport within 54 months in patients on long term peritoneal dialysis (PD), despite a high rate of peritoneal infection.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
